Jim Simons Virios Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.46 - $0.9 $88,641 - $173,428	192,698 Added 1376.51%	206,697 $119,000
Q3 2023 Nov 14, 2023	SELL	$0.86 - $2.42 $27,864 - $78,410	-32,401 Reduced 69.83%	13,999 $13,000
Q2 2023 Aug 11, 2023	SELL	$0.35 - $1.94 $700 - $3,880	-2,000 Reduced 4.13%	46,400 $64,000
Q1 2023 May 12, 2023	SELL	$0.24 - $0.44 $44,880 - $82,280	-187,000 Reduced 79.44%	48,400 $18,000
Q4 2022 Feb 13, 2023	BUY	$0.24 - $0.39 $14,112 - $22,932	58,800 Added 33.3%	235,400 $56,000
Q3 2022 Nov 14, 2022	BUY	$0.37 - $8.77 $65,342 - $1.55 Million	176,600 New	176,600 $67,000

991K

Ticker VIRI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,330,400
Market Cap $3.12M
Description
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.